Cargando…
Search strategies to identify reports on “off-label” drug use in EMBASE
BACKGROUND: Medications are frequently prescribed outside their regulatory approval (off-label) by physicians particularly where appropriate therapies are not available. However, the risk/benefit ratio of drugs in off-label use needs to be critically appraised because it may differ from approved on-...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3543848/ https://www.ncbi.nlm.nih.gov/pubmed/23272771 http://dx.doi.org/10.1186/1471-2288-12-190 |
_version_ | 1782255708586115072 |
---|---|
author | Mesgarpour, Bita Müller, Markus Herkner, Harald |
author_facet | Mesgarpour, Bita Müller, Markus Herkner, Harald |
author_sort | Mesgarpour, Bita |
collection | PubMed |
description | BACKGROUND: Medications are frequently prescribed outside their regulatory approval (off-label) by physicians particularly where appropriate therapies are not available. However, the risk/benefit ratio of drugs in off-label use needs to be critically appraised because it may differ from approved on-label usage. Therefore, an extensive exploration of current evidence on clinical data is well-advised. The objective of this study was to develop a search strategy that facilitates detection of the off-label drug use documents in EMBASE via OvidSP. METHODS: We constructed two sets of gold standards from relevant records to off-label drug use by a sensitive search of MEDLINE and EMBASE. Search queries, including search words and strings, were conceived based on definition of off-label use of medications as well as text analysis of 500 randomly selected relevant documents. The selected terms were searched in EMBASE (from 1988 to 2011) and their retrieval performance was compared with the gold standards. We developed a sensitivity-maximizing, and a sensitivity- and precision-maximizing search strategy. RESULTS: From 4067 records relevant to off-label drug use in our full gold standard set, 3846 records were retrievable from EMBASE. “off label*.af.” was the most sensitive single term (overall sensitivity 77.5%, sensitivity within EMBASE 81.9%, precision 88.1%). The highest sensitive search strategy was achieved by combining 36 search queries with overall sensitivity of 94.0% and precision of 69.5%. An optimal sensitive and precise search strategy was yielded precision 87.4% at the expense of decreasing overall sensitivity to 89.4%. CONCLUSION: We developed highly sensitive search strategies to enhance the retrieval of studies on off-label drug use in OvidSP EMBASE. |
format | Online Article Text |
id | pubmed-3543848 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-35438482013-01-14 Search strategies to identify reports on “off-label” drug use in EMBASE Mesgarpour, Bita Müller, Markus Herkner, Harald BMC Med Res Methodol Research Article BACKGROUND: Medications are frequently prescribed outside their regulatory approval (off-label) by physicians particularly where appropriate therapies are not available. However, the risk/benefit ratio of drugs in off-label use needs to be critically appraised because it may differ from approved on-label usage. Therefore, an extensive exploration of current evidence on clinical data is well-advised. The objective of this study was to develop a search strategy that facilitates detection of the off-label drug use documents in EMBASE via OvidSP. METHODS: We constructed two sets of gold standards from relevant records to off-label drug use by a sensitive search of MEDLINE and EMBASE. Search queries, including search words and strings, were conceived based on definition of off-label use of medications as well as text analysis of 500 randomly selected relevant documents. The selected terms were searched in EMBASE (from 1988 to 2011) and their retrieval performance was compared with the gold standards. We developed a sensitivity-maximizing, and a sensitivity- and precision-maximizing search strategy. RESULTS: From 4067 records relevant to off-label drug use in our full gold standard set, 3846 records were retrievable from EMBASE. “off label*.af.” was the most sensitive single term (overall sensitivity 77.5%, sensitivity within EMBASE 81.9%, precision 88.1%). The highest sensitive search strategy was achieved by combining 36 search queries with overall sensitivity of 94.0% and precision of 69.5%. An optimal sensitive and precise search strategy was yielded precision 87.4% at the expense of decreasing overall sensitivity to 89.4%. CONCLUSION: We developed highly sensitive search strategies to enhance the retrieval of studies on off-label drug use in OvidSP EMBASE. BioMed Central 2012-12-29 /pmc/articles/PMC3543848/ /pubmed/23272771 http://dx.doi.org/10.1186/1471-2288-12-190 Text en Copyright ©2012 Mesgarpour et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Mesgarpour, Bita Müller, Markus Herkner, Harald Search strategies to identify reports on “off-label” drug use in EMBASE |
title | Search strategies to identify reports on “off-label” drug use in EMBASE |
title_full | Search strategies to identify reports on “off-label” drug use in EMBASE |
title_fullStr | Search strategies to identify reports on “off-label” drug use in EMBASE |
title_full_unstemmed | Search strategies to identify reports on “off-label” drug use in EMBASE |
title_short | Search strategies to identify reports on “off-label” drug use in EMBASE |
title_sort | search strategies to identify reports on “off-label” drug use in embase |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3543848/ https://www.ncbi.nlm.nih.gov/pubmed/23272771 http://dx.doi.org/10.1186/1471-2288-12-190 |
work_keys_str_mv | AT mesgarpourbita searchstrategiestoidentifyreportsonofflabeldruguseinembase AT mullermarkus searchstrategiestoidentifyreportsonofflabeldruguseinembase AT herknerharald searchstrategiestoidentifyreportsonofflabeldruguseinembase |